114 related articles for article (PubMed ID: 28910745)
1. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14.
Guo Y; Liao Y
Int Immunopharmacol; 2017 Nov; 52():150-155. PubMed ID: 28910745
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways.
Chen H; Liu W; Wu X; Gou M; Shen J; Wang H
Int Immunopharmacol; 2017 Nov; 52():143-149. PubMed ID: 28910744
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
Sasaki Y; Shimizu Y; Suzuki Y; Horikoshi S; Tomino Y
BMC Nephrol; 2015 Mar; 16():27. PubMed ID: 25885587
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a-3p directly targets FosB to regulate cell proliferation, apoptosis, and inflammation responses in immunoglobulin a nephropathy.
Liao Y; Wang Z; Wang L; Lin Y; Ye Z; Zeng X; Wei F
Biochem Biophys Res Commun; 2020 Sep; 529(4):1124-1130. PubMed ID: 32819575
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of miRNA-21 prevents fibrogenic activation in podocytes and tubular cells in IgA nephropathy.
Bao H; Hu S; Zhang C; Shi S; Qin W; Zeng C; Zen K; Liu Z
Biochem Biophys Res Commun; 2014 Feb; 444(4):455-60. PubMed ID: 24468088
[TBL] [Abstract][Full Text] [Related]
6. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
7. MiR-100-3p and miR-877-3p regulate overproduction of IL-8 and IL-1β in mesangial cells activated by secretory IgA from IgA nephropathy patients.
Liang Y; Zhao G; Tang L; Zhang J; Li T; Liu Z
Exp Cell Res; 2016 Oct; 347(2):312-21. PubMed ID: 27542871
[TBL] [Abstract][Full Text] [Related]
8. Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
Tezuka Y; Eguchi-Ishimae M; Ozaki E; Ito T; Ishii E; Eguchi M
PLoS One; 2021; 16(10):e0258090. PubMed ID: 34597335
[TBL] [Abstract][Full Text] [Related]
9. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
Uhlmann S; Zhang JD; Schwäger A; Mannsperger H; Riazalhosseini Y; Burmester S; Ward A; Korf U; Wiemann S; Sahin O
Oncogene; 2010 Jul; 29(30):4297-306. PubMed ID: 20514023
[TBL] [Abstract][Full Text] [Related]
10. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson's Disease.
Samidurai M; Tarale P; Janarthanam C; Estrada CG; Gordon R; Zenitsky G; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
Cells; 2020 Aug; 9(8):. PubMed ID: 32759670
[TBL] [Abstract][Full Text] [Related]
11. SPAK plays a pathogenic role in IgA nephropathy through the activation of NF-κB/MAPKs signaling pathway.
Lin TJ; Yang SS; Hua KF; Tsai YL; Lin SH; Ka SM
Free Radic Biol Med; 2016 Oct; 99():214-224. PubMed ID: 27519267
[TBL] [Abstract][Full Text] [Related]
12. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma.
Xu RD; Feng F; Yu XS; Liu ZD; Lao LF
Int J Immunopathol Pharmacol; 2018; 32():2058738418786656. PubMed ID: 30014744
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
Yang L; Zhang X; Peng W; Wei M; Qin W
Int Urol Nephrol; 2017 Feb; 49(2):353-361. PubMed ID: 27796698
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal region of tumor necrosis factor like weak inducer of apoptosis is required for interaction with advanced glycation end products.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Biotechnol Appl Biochem; 2019 Mar; 66(2):254-260. PubMed ID: 30403295
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-889 Inhibits Autophagy To Maintain Mycobacterial Survival in Patients with Latent Tuberculosis Infection by Targeting TWEAK.
Chen DY; Chen YM; Lin CF; Lo CM; Liu HJ; Liao TL
mBio; 2020 Jan; 11(1):. PubMed ID: 31992621
[TBL] [Abstract][Full Text] [Related]
16. TRAF3IP2 mediates TWEAK/TWEAKR-induced pro-fibrotic responses in cultured cardiac fibroblasts and the heart.
Das NA; Carpenter AJ; Yoshida T; Kumar SA; Gautam S; Mostany R; Izadpanah R; Kumar A; Mummidi S; Siebenlist U; Chandrasekar B
J Mol Cell Cardiol; 2018 Aug; 121():107-123. PubMed ID: 29981796
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.
Sheng X; Zuo X; Liu X; Zhou Y; Sun X
Int Urol Nephrol; 2018 Apr; 50(4):779-785. PubMed ID: 29230705
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy
.
Kim JS; Jeong KH
Clin Nephrol; 2020 Feb; 93(2):99-105. PubMed ID: 31829928
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis.
Srivastava A; Luo L; Lohcharoenkal W; Meisgen F; Pasquali L; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2021 Jun; 147(6):2225-2235. PubMed ID: 33705829
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end products attenuate the function of tumor necrosis factor-like weak inducer of apoptosis to regulate the inflammatory response.
Watanabe M; Toyomura T; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
Mol Cell Biochem; 2017 Oct; 434(1-2):153-162. PubMed ID: 28455790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
